Resflok

Resflok

sparfloxacin

Manufacturer:

Sanbe
Concise Prescribing Info
Contents
Sparfloxacin
Indications/Uses
Lower resp tract infection, community-acquired pneumonia, acute exacerbation of COPD.
Dosage/Direction for Use
Adult Community-acquired pneumonia & acute exacerbation of COPD Initially 400 mg as a single dose on day 1, then 200 mg daily for 10 days.
Administration
May be taken with or without food.
Contraindications
Hypersensitivity to sparfloxacin & other quinolones. Patients w/ a history of muscle/tendon disease due to fluoroquinolones; G6PD deficiency. Pregnancy & lactation. Infant, childn & adolescents.
Special Precautions
Avoid exposure to sunlight or UV radiation until 5 days after the end of treatment. May prolong the QT interval. Tendonitis or tendon impairment.
Adverse Reactions
GI disorders, insomnia, somnolence, convulsion, skin reaction, photosensitivity, rash or urticaria. Transient rise in liver transaminases.
Drug Interactions
Sucralfate, Fe sulfate, Al- or Mg-containing antacids may decrease sparfloxacin absorption. Increased conc w/ digoxin. Cisapride may result in increased absorption.
MIMS Class
Quinolones
ATC Classification
J01MA09 - sparfloxacin ; Belongs to the class of fluoroquinolones. Used in the systemic treatment of infections.
Presentation/Packing
Form
Resflok FC tab 200 mg
Packing/Price
3 × 6's (Rp344,340/boks)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in